Related Experiment Video

Updated: Jul 9, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Early local intracoronary platelet activation after drug-eluting stent placement

Ailiman Mahemuti1, Nicolas Meneveau, Marie-France Seronde

  • 1Department of Cardiology and UPRES EA3920-IFR133, University of Franche-Comte Medical School, Jean-Minjoz University Hospital, Bensancon, France. xahzad@hotmail.com

Chinese Medical Journal
|December 11, 2007
PubMed

Insights

Dual anti-platelet therapy prevents local platelet activation after drug-eluting stent implantation in stable angina patients. This finding is crucial for understanding acute stent thrombosis risks.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Platelet Biology

Background:

  • Early local platelet activation post-coronary intervention is linked to increased acute stent thrombosis (AST) risk.
  • Previous research has not reported on early platelet activation changes in coronary circulation after drug-eluting stent (DES) implantation.

Purpose of the Study:

  • To investigate early changes in platelet activation markers in the coronary circulation following drug-eluting stent (DES) and bare metal stent (BMS) implantation.
  • To determine if dual anti-platelet therapy affects local platelet activation immediately after stenting in stable angina patients.

Main Methods:

  • Prospective study of 26 stable angina patients undergoing elective percutaneous coronary intervention (PCI).
  • Measurement of soluble glycoprotein V (sGPV) and P-selectin (CD62P) levels before and after stent implantation.
  • Blood samples collected from coronary ostium and distal to the lesion site in patients pretreated with clopidogrel and aspirin.

Main Results:

  • Baseline levels of CD62P and sGPV were within normal ranges in both coronary ostium and distal sites.
  • No significant changes in CD62P or sGPV levels were observed post-stent implantation compared to baseline (P > 0.05 for both).
  • Platelet activation marker changes did not differ between DES and BMS groups.

Conclusions:

  • Intracoronary local platelet activation does not occur immediately following DES implantation in stable angina patients receiving dual anti-platelet therapy.
  • Dual anti-platelet therapy effectively inhibits local platelet activation in the coronary circulation post-stenting.
Abstract

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.